India Panel Delays Vote On $1.6B Mylan, Agila Merger
India's Foreign Investment Promotion Board on Friday delayed approving Mylan Inc.'s $1.6 billion proposed merger with Agila Specialties Private Ltd., a generic-drug manufacturing division of locally based Strides Arcolab Ltd. —...To view the full article, register now.
Already a subscriber? Click here to view full article